Mechanism of Notch Signaling Pathway in Malignant Progression of Glioblastoma and Targeted Therapy
Biomolecules · 2024
DOI: 10.3390/biom14040480 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2024. Verfasst von Shenghao Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Medical Research Institute, Southwest University, Chongqing 400716, China. Hauptthemen laut MEDLINE: Glioblastoma, Signal Transduction, Receptors, Notch. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The pilot program of Southwest University, Natural Science Foundation of Chongqing.
Abstract (Originalsprache)
Glioblastoma multiforme (GBM) is the most aggressive form of glioma and the most common primary tumor of the central nervous system. Despite significant advances in clinical management strategies and diagnostic techniques for GBM in recent years, it remains a fatal disease. The current standard of care includes surgery, radiation, and chemotherapy, but the five-year survival rate for patients is less than 5%. The search for a more precise diagnosis and earlier intervention remains a critical and urgent challenge in clinical practice. The Notch signaling pathway is a critical signaling system that has been extensively studied in the malignant progression of glioblastoma. This highly conserved signaling cascade is central to a variety of biological processes, including growth, proliferation, self-renewal, migration, apoptosis, and metabolism. In GBM, accumulating data suggest that the Notch signaling pathway is hyperactive and contributes to GBM initiation, progression, and treatment resistance. This review summarizes the biological functions and molecular mechanisms of the Notch signaling pathway in GBM, as well as some clinical advances targeting the Notch signaling pathway in cancer and glioblastoma, highlighting its potential as a focus for novel therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Center, Medical Research Institute, Southwest University, Chongqing 400716, China.
- State Key Laboratory of Resource Insects, Southwest University, Chongqing 400716, China.
- Department of Neurosurgery, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
ORCID-Profile: Hongjuan Cui
Förderung
- The pilot program of Southwest University
- Natural Science Foundation of Chongqing
Zitieren
APA
Wang, S., Gu, S., Chen, J., Yuan, Z., Liang, P., & Cui, H. (2024). Mechanism of Notch Signaling Pathway in Malignant Progression of Glioblastoma and Targeted Therapy. Biomolecules. https://doi.org/10.3390/biom14040480
Vancouver
Wang S, Gu S, Chen J, Yuan Z, Liang P, Cui H. Mechanism of Notch Signaling Pathway in Malignant Progression of Glioblastoma and Targeted Therapy. Biomolecules. 2024. doi:10.3390/biom14040480
BibTeX
@article{Wang2024,
author = {Wang, Shenghao and Gu, Sikuan and Chen, Junfan and Yuan, Zhiqiang and Liang, Ping and Cui, Hongjuan},
title = {Mechanism of Notch Signaling Pathway in Malignant Progression of Glioblastoma and Targeted Therapy},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14040480}
}
EUVIMED